Medicaid expansion under the Affordable Care Act (ACA) is associated with better outcomes for patients with hormone receptor (HR)-negative, human...

The Committee for Medicinal Products for Human Use adopted a positive opinion for NVS' Kisqali to help reduce the risk of recurrence in people with...

FRIDAY, Oct. 25, 2024 -- Expanding Medicaid is associated with an increase in receipt of guideline-concordant treatment among nonelderly women newly...

THURSDAY, Oct. 31, 2024 -- Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus...

HER2-targeted therapies, originally developed for breast cancer, may also benefit patients with rare bile duct cancer and HER2-mutated breast...

Drugs aimed at HER2-positive breast cancer may also help certain patients with bile duct cancer, as indicated by findings from a patient trial that...

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast...

THE EDITOR, Madam: This month brings attention to heroes — those fighting a different battle: breast cancer survivors. October is Breast Cancer...

BriaCell Therapeutics (TSX:BCT) reveals new positive survival data in its Phase 2 metastatic breast cancer study.